Human neutrophils release serine proteases capable of activating prorenin.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Circulation Research

• Publication date

  1987-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.60.4.595PMID 3297385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of human prorenin expressed in mammalian cells from cloned cDNA.

  1986cited by this paper
• Immunological evidence that inactive renin is prorenin.

  1985cited by this paper
• Immunologic identification of both plasma and human renal inactive renin as prorenin.

  1985cited by this paper
• Identification of plasma inactive renin as prorenin with a site-directed antibody.

  1985cited by this paper
• Potential effects of renin activation on the regulation of renin production.

  1984cited by this paper
• Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis.

  1984cited by this paper
• Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G.

  1984cited by this paper
• Characterization of inactive renin from human kidney and plasma. Evidence of a renal source of circulating inactive renin.

  1983cited by this paper
• Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

  1982cited by this paper
• Role of angiotensin-converting enzyme in Bacille Calmette-Guérin-induced granulomatous inflammation. Increased angiotensin-converting enzyme levels in lung lavage and suppression of inflammation with captopril.

  1982cited by this paper
• Evidence for renin in rat brain: differentiation from other reninlike enzymes.

  1982cited by this paper
• The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G.

  1982cited by this paper
• Inhibition of vascular permeability changes in rats by captopril.

  1982cited by this paper
• Inhibition of vascular permeability changes by captopril

  1981cited by this paper
• Control of vascular permeability by polymorphonuclear leukocytes in inflammation

  1981cited by this paper
• Pure human renin. Identification and characterization and of two major molecular weight forms.

  1981cited by this paper
• Effect of SQ 14225, an inhibitor of angiotensin I-converting enzyme, on the granulomatous response to Schistosoma mansoni eggs in mice.

  1981cited by this paper
• Detection and Isolation of Inactive, Large Molecular Weight Renin in Human Kidney and Plasma

  1981cited by this paper
• Angiotensin II Stimulation of Renal Prostaglandin Synthesis Elevates Circulating Prostacyclin in the Dog

  1980cited by this paper
• Angiotensin II stimulation of renal prostaglandin synthesis elevates circulating prostacyclin in the dog.

  1980cited by this paper
• Prorenin and other large molecular weight forms of renin.

  1980cited by this paper
• A neutrophil-dependent pathway for the generation of a neutral peptide mediator. II. Subcellular localization of the neutrophil protease.

  1977cited by this paper
• Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins.

  1977cited by this paper
• Human leukocyte granule elastase: rapid isolation and characterization.

  1976cited by this paper
• The synthesis and analytical use of a highly sensitive and convenient substrate of elastase.

  1974cited by this paper
• Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

  1969cited by this paper
• SERUM LACTIC DEHYDROGENASE ACTIVITY: AN ANALYTICAL ASSESSMENT OF CURRENT ASSAYS.

  1963cited by this paper
• A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin.

  1959cited by this paper
• Chromogenic substrates; phenolphthalein glucuronic acid as substrate for the assay of glucuronidase activity.

  1946cited by this paper

• Paneth Cells: Recent Updates on Elucidating Therapeutic Implications in Gastroenterological Disease Management.

  2025cites this paper
• A noncanonical‐GPRC5A signaling regulates keratinocyte adhesion and migration by nuclear translocation

  2025cites this paper
• Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis

  2022cites this paper
• Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled

  2021cites this paper
• Cathepsin G—Not Only Inflammation: The Immune Protease Can Regulate Normal Physiological Processes

  2020cites this paper
• Immunolocalization of the complement component C1q in the mucous membrane of the human duodenum (duodenitis II-III degree)

  2019cites this paper
• Cathepsin G in the immune defense of the human duodenum: New sources for biosynthesis

  2017cites this paper
• Untersuchung der proteolytischen Prozessierung von humanen Angiotensin-Peptiden

  2013cites this paper
• Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice.

  2013cites this paper
• Role of Cathepsin G in Atherosclerosis

  2013cites this paper
• Co-operative effects of angiotensin II and caerulein in NFκB activation in pancreatic acinar cells in vitro.

  2011cites this paper
• Anti-Inflammatory Effects of Anti-Hypertensive Agents: Influence on Interleukin-1β Secretion by Peripheral Blood Polymorphonuclear Leukocytes from Patients with Essential Hypertension

  2011cites this paper
• New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease

  2010cites this paper
• Biochemical properties of renin and prorenin binding to the (pro)renin receptor

  2010cites this paper
• Involvement of Redox-Sensitive Extracellular-Regulated Kinases in Angiotensin II-Induced Interleukin-6 Expression in Pancreatic Acinar Cells

  2009cites this paper
• Renin–angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation

  2008cites this paper
• Influência da castração sobre o comportamento leucocitário e expressão de moléculas de adesão na microcirculação mesentérica de ratos.

  2008cites this paper
• The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren.

  2007cites this paper
• Association of white blood cell count with systolic blood pressure within the normotensive range

  2006cites this paper
• Role of p90 Ribosomal S6 Kinase–Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium

  2006cites this paper
• Comment Do Leukocytes Have a Role in Hypertension ?

  2005cites this paper
• Inflammation and angiotensin II.

  2003cites this paper
• Leukocyte angiotensin II levels inpatients with essential hypertension:relation to insulin resistance.

  2003cites this paper
• Implications physiopathologiques et cliniques des r??cepteurs AT1/AT2 de l??angiotensine II dans l??insuffisance cardiaque, coronaire et r??nale

  2002cites this paper
• [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].

  2002cites this paper
• Angiotensin II: a double-edged sword in inflammation.

  2000cites this paper
• Evolution and Pathophysiology of Chronic Systolic Heart Failure

  2000cites this paper
• Blocking the tissue renin-angiotensin system: the future cornerstone of therapy

  2000cites this paper
• Angiotensin II-Generating Enzymes

  2000cites this paper
• Pharmakologie und klinische Pharmakologie der AT1-Rezeptorantagonisten

  1999cites this paper
• Pharmakologische Aspekte von Angiotensin-II-Rezeptoren und AT1-Rezeptorantagonisten

  1999cites this paper
• Effects of human prorenin in rats transgenic for human angiotensinogen.

  1999cites this paper
• Angiotensin II receptor pharmacology and AT1-receptor blockers

  1999cites this paper
• Pharmacology of angiotensin receptors and AT1 receptor blockers

  1998cites this paper
• Leukocyte activation in atherosclerosis: correlation with risk factors.

  1997cites this paper
• Neutrophil Degranulation Activity in Preeclampsia

  1997cites this paper
• Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions.

  1996cites this paper
• Cathepsin B is a prorenin processing enzyme.

  1996cites this paper
• Properties of circulating leukocytes in spontaneously hypertensive rats.

  1995cites this paper
• Circulating leukocyte counts, activation, and degranulation in Dahl hypertensive rats.

  1995cites this paper
• Proteases.

  1995cites this paper
• Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury.

  1995cites this paper
• Polymorphonuclear leukocytes in ischemic vascular disease.

  1994cites this paper
• [Complement system activation and the reactions of the cardiovascular system].

  1994cites this paper
• Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.

  1993cites this paper
• Regulation of renin processing and secretion: chemiosmotic control and novel secretory pathway.

  1993cites this paper
• Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes.

  1993cites this paper
• Involvement of nitric oxide in the endothelium‐dependent relaxation induced by hydrogen peroxide in the rabbit aorta

  1993cites this paper
• Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis.

  1992cites this paper
• Release of Proinflammatory and Prothrombotic Mediators in the Brain and Peripheral Circulation in Spontaneously Hypertensive and Normotensive Wistar‐Kyoto Rats

  1992cites this paper
• [Modulation of vascular tone of normal and arteriosclerotic arteries by leukocytes].

  1992cites this paper
• Effects of prorenin on blood pressure and plasma renin concentrations in stroke-prone spontaneously hypertensive rats.

  1992cites this paper
• Characterization of prorenin activation using a synthetic peptide substrate.

  1991cites this paper
• Differing renal effects of activated and nonactivated isoelectric peaks of human prorenin in rats.

  1991cites this paper
• Do Leukocytes Have a Role in Hypertension?

  1991cites this paper
• Human Prorenin

  1991cites this paper
• Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses.

  1989cites this paper
• Synthetic peptide inhibitors of prorenin activation

  1989cites this paper
• Role of Molecular Biology in Hypertension Research State of the Art Lecture

  1989cites this paper
• Is prorenin of physiological and clinical significance?

  1988cites this paper
• Molecular biology of the renin-angiotensin system.

  1988cites this paper
• Partial purification of a prorenin activating enzyme in the aortic wall.

  1988cites this paper
• Activation of human prorenin by neutrophil elastase.

  1987cites this paper